BioSpace News Archive

Business

IDEXX Laboratories to Release 2019 Third Quarter Financial Results

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled the release of its 2019 third quarter financial results for Thursday, October 31, 2019 before the market opens.

October 10, 2019
·
1 min read
BioCapital

FDA allows marketing of first rapid diagnostic test for detecting Ebola virus antigens

Today, the U.S. Food and Drug Administration allowed marketing of a rapid diagnostic test (RDT) to detect Ebola virus antigens (proteins) in human blood from certain living individuals and samples from certain recently deceased individuals suspected to have died from Ebola (cadaveric oral fluid).

October 10, 2019
·
7 min read
Business

Vantage EyeCare, LLC at 2019 American Academy of Ophthalmology Annual Meeting

The physicians and surgeons of Vantage EyeCare, LLC will be out in force at the American Academy of Ophthalmology’s Annual Meeting in San Francisco, October 11 – 15, 2019, sharing their expertise and learning from their peers.

October 10, 2019
·
3 min read
Biotech Beach

Medical Marijuana, Inc. Subsidiary Kannaway® Announces Launch of New Website and Back Office for Japan Division

Medical Marijuana, Inc. announced that its subsidiary Kannaway® has launched a new website and back office available in Japanese catered to servicing the expansion into Japan and Asia.

October 10, 2019
·
4 min read
Biotech Beach

Fastest Growing Fertility Pharmacy to Deliver Enhanced Services and Programs to West Coast Clinics

Florida-based SMP Pharmacy Solutions announces strategic acquisition of Northridge Plaza Pharmacy to serve growing demand in California fertility market

October 10, 2019
·
2 min read
Deals

Phitonex Announces $2M Seed Funding

Fluorescent Dye Platform Will Enable New Breadth and Depth in Single Cell Analysis

October 10, 2019
·
2 min read
Deals

Ginkgo Bioworks Announces the Ferment Consortium, a $350 Million Investment Vehicle to Disrupt Established Markets with New Synthetic Biology Companies

New investment vehicle to support the launch of companies with capital, network of strategic partners, and access to Ginkgo’s platform for cell programming

October 10, 2019
·
3 min read
Pharm Country

Hillstream BioPharma Announces Renewal of CRADA with National Center for Advancing Translational Sciences for Use of QUATRAMER™ Drug Delivery Technology with HDAC6-PI3Kδ Dual Inhibitor for AML

Hillstream BioPharma Inc. (“Hillstream”) today announced the renewal of a Cooperative Research and Development Agreement (CRADA) with the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH).

October 10, 2019
·
2 min read
Policy

SHAREHOLDER ALERT: WeissLaw LLP Investigates Ra Pharmaceuticals, Inc.

WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the Board of Ra Pharmaceuticals, Inc. in connection with the proposed acquisition of the Company by UCB S.A.

October 10, 2019
·
2 min read